Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Fragile X Syndrome – Epidemiology – Epidemiology – Fragile X Syndrome – Mature Markets
Clarivate Epidemiology’s coverage of fragile X syndrome (FXS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France…
Schizophrenia – Unmet Need – Unmet Need – Cognitive Impairment Associated with Schizophrenia (US/EU)
CIAS (e.g., impaired attention / vigilance, memory, and/or executive function) negatively impacts patients’ daily activities, occupational and social functioning, and adherence to antipsychotic…
Major Depressive Disorder (DSM-V) – Current Treatment – Current Treatment: Physician Insights – Major Depressive Disorder (EU5)
Agents for treating major depressive disorder (MDD) span multiple drug classes; while selective serotonin reuptake inhibitors (SSRIs) and serotonin / norepinephrine reuptake inhibitors (SNRIs) are…
Schizophrenia – Current Treatment – Current Treatment: Physician Insights – Schizophrenia (US)
In the United States, atypical antipsychotics available in oral and injectable (e.g., long-acting injectable [LAI]) formulations are the mainstay of schizophrenia treatment. However, the dearth of…
Post-Traumatic Stress Disorder – Executive Insights – Executive Insights – Post-Traumatic Stress Disorder (US)
Post-traumatic stress disorder (PTSD) is a chronic psychiatric condition that may emerge after a person experiences a traumatic event or series of events. Multiple guidelines recommend first…
Obsessive-Compulsive Disorder – Current Treatment – Treatment Algorithms: Claims Data Analysis – Obsessive-Compulsive Disorder (US)
Obsessive-compulsive disorder (OCD) is characterized by repeated intrusive thoughts, uncontrollable repetitive behaviors, or both. First-line OCD therapy commonly includes psychotherapy but may…
